Indiscriminate use of antimicrobials affects not just the bugs that cause disease but also our friendly resident microbes and contributes to antimicrobial resistance. How can we develop new therapies for effective treatment of infections without causing resistance? What is stopping new antimicrobial development?

Speakers: Dr Karen Scott (Senior Research Fellow, Rowett Institute, University of Aberdeen) and Dr Soumya Palliyil (Head of Scottish Biologics Facility)